A detailed history of Cypress Wealth Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cypress Wealth Services, LLC holds 1,850 shares of NVS stock, worth $190,679. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,850
Holding current value
$190,679
% of portfolio
0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$106.13 - $120.89 $196,340 - $223,646
1,850 New
1,850 $212,000
Q1 2024

Apr 15, 2024

BUY
$95.27 - $108.47 $198,542 - $226,051
2,084 New
2,084 $201,000
Q2 2021

Jul 14, 2021

SELL
$85.24 - $94.15 $209,349 - $231,232
-2,456 Closed
0 $0
Q1 2021

Apr 28, 2021

BUY
$83.5 - $98.47 $7,765 - $9,157
93 Added 3.94%
2,456 $210,000
Q4 2020

Jan 22, 2021

BUY
$78.07 - $94.43 $184,479 - $223,138
2,363 New
2,363 $223,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cypress Wealth Services, LLC Portfolio

Follow Cypress Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Wealth Services, LLC with notifications on news.